[{"AccountsPayableCurrent_0_Q2_USD":5515000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q2_USD":58818000.0,"EarningsPerShareDiluted_2_Q2_USD":1.05,"EarningsPerShareDiluted_1_Q2_USD":0.65,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":18382000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":17418000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":163839000.0,"OtherNonoperatingIncome_2_Q2_USD":3528000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":210975000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":257936000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":408272000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4962000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8950000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":11995000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":9560000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":358673000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":-984000.0,"OtherNonoperatingIncome_1_Q2_USD":3326000.0,"InvestmentIncomeInterest_1_Q2_USD":4151000.0,"OtherAssetsNoncurrent_0_Q2_USD":17118000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52545910.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":52557035.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":13041000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":24000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":46192000.0,"InvestmentIncomeInterest_2_Q2_USD":9726000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":60127000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":3942000.0,"InterestExpenseDebt_1_Q2_USD":4792000.0,"InterestExpenseDebt_2_Q2_USD":9485000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-3062000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":5044000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":11525000.0,"MarketableSecuritiesCurrent_0_Q2_USD":163839000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1088793.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1065508.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-2731000.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q2_USD":7262000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":10658000.0,"MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments_2_Q2_USD":3316000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3560000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":1176000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":30108000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":11525000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":3942000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":297200000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":15382000.0,"PaymentsToAcquireOtherInvestments_2_Q2_USD":15000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":126729000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":21289000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":10913000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":22513000.0,"GoodwillGross_0_Q2_USD":88095000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":12957000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4962000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":8179000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q2_USD":4200000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":15525000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":388000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":507375000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":522512000.0,"BusinessCombinationConsiderationTransferred1_2_Q2_USD":115700000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":23500000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":92200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":29594000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_2_Q2_USD":0.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":4201000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":22479000.0,"Goodwill_0_Q2_USD":88095000.0,"EarningsPerShareBasic_2_Q2_USD":1.07,"EarningsPerShareBasic_1_Q2_USD":0.66,"CostOfGoodsAndServicesSold_2_Q2_USD":12538000.0,"Liabilities_0_Q2_USD":825046000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1491020000.0,"LiabilitiesCurrent_0_Q2_USD":269276000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1469000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-72742000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":100867000.0,"InventoryNet_0_Q2_USD":35338000.0,"NetIncomeLoss_2_Q2_USD":56185000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3072000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":20442000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":1469000.0,"ProfitLoss_2_Q2_USD":56185000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":17941000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":255733000.0,"NetIncomeLoss_1_Q2_USD":34667000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":20431000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-7199000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":12543000.0,"AccountsReceivableNetCurrent_0_Q2_USD":126559000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":25052000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":11359000.0,"AdditionalPaidInCapital_0_Q2_USD":398829000.0,"Assets_0_Q2_USD":1491020000.0,"AssetsCurrent_0_Q2_USD":557153000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":210975000.0,"CommonStockSharesIssued_0_Q2_shares":52624084.0,"CommonStockSharesOutstanding_0_Q2_shares":52624084.0,"CommonStockValue_0_Q2_USD":53000.0,"CostsAndExpenses_1_Q2_USD":81181000.0,"CostsAndExpenses_2_Q2_USD":147145000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":47210000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":76244000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":20059000.0,"StockholdersEquity_0_Q2_USD":665974000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":221705000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ConvertibleLongTermNotesPayable_0_Q2_USD":353349000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":53611418.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":13799000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":2445000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":3706000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":35716000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.266,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":53645828.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.263,"PropertyPlantAndEquipmentGross_0_Q2_USD":31740000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":10090000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":80.9063,"OtherNonoperatingIncomeExpense_1_Q2_USD":1662000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1684000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":8386000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-1689000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":8950000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":89717000.0,"DepreciationAndAmortization_1_Q2_USD":600000.0,"DepreciationAndAmortization_2_Q2_USD":1100000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":22242000.0,"IncomeTaxesPaidNet_2_Q2_USD":607000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":408272000.0,"InterestExpense_2_Q2_USD":11570000.0,"InterestExpense_1_Q2_USD":5815000.0,"InterestExpenseOther_1_Q2_USD":1023000.0,"InterestExpenseOther_2_Q2_USD":2085000.0,"InterestPaidNet_2_Q2_USD":1258000.0,"OperatingIncomeLoss_1_Q2_USD":45548000.0,"OperatingIncomeLoss_2_Q2_USD":74560000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":22247000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":41184000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":48103000.0,"CommonStockSharesAuthorized_0_Q2_shares":130000000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":981000.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200817"}]